PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 23 filers reported holding PROQR THRAPEUTICS N V in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $74,000 | -15.9% | 11,100 | -38.7% | 0.00% | -50.0% |
| Q2 2016 | $88,000 | 0.0% | 18,100 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $88,000 | -43.9% | 18,100 | 0.0% | 0.00% | -33.3% |
| Q4 2015 | $157,000 | -40.5% | 18,100 | 0.0% | 0.00% | -40.0% |
| Q3 2015 | $264,000 | -12.6% | 18,100 | 0.0% | 0.01% | 0.0% |
| Q2 2015 | $302,000 | -20.7% | 18,100 | +4.0% | 0.01% | -28.6% |
| Q1 2015 | $381,000 | +1.1% | 17,400 | 0.0% | 0.01% | 0.0% |
| Q4 2014 | $377,000 | +550.0% | 17,400 | +411.8% | 0.01% | +600.0% |
| Q3 2014 | $58,000 | – | 3,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Privium Fund Management B.V. | 5,344,446 | $18,010,783 | 6.83% |
| M28 Capital Management LP | 1,910,600 | $7,069,220 | 6.74% |
| Opaleye Management Inc. | 1,460,000 | $5,402,000 | 1.88% |
| Ikarian Capital, LLC | 422,625 | $1,563,713 | 0.38% |
| Monaco Asset Management SAM | 165,000 | $610,500 | 0.18% |
| AWM Investment Company, Inc. | 166,667 | $616,668 | 0.09% |
| FRANKLIN STREET ADVISORS INC /NC | 150,000 | $555 | 0.05% |
| Atom Investors LP | 18,522 | $68,531 | 0.03% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,625,467 | $13,414,228 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 21,514 | $80 | 0.01% |